Last month, Life Sciences marketing, commercial and medical leaders from across the country gathered at Reuter’s Pharma Customer Engagement to address current challenges and share industry best practices. In this episode, Jen is joined by Vynamic’s Customer Experience Transformation Lead, Mike Zapiec, and Head of Life Sciences, Karen Baldry to shar…

With the first round of CMS price negotiations behind us, and the next list of targets to be released in February 2026, it’s clear that theorized implications from the Inflation Reduction Act are becoming realities for the life sciences industry. In this episode, Jen and Mindy are joined by Putnam Associates Partner, Scott Briggs, to explore how co…

With increasing pressure to bring products to market faster than ever, Life Sciences companies need to balance supply chain speed with global complexities, regulatory hurdles, and digital integration to maintain competitiveness. In this episode, Jen is joined by Vynamic’s Dan Ahern and Roche Product Strategy Leader within Global Supply Chain, Devon…

Organizational AI adoption has dramatically increased over the years largely due to generative AI, leaving organizations to navigate challenges while rapidly scaling and adopting new technologies. In this episode, Jen is joined by Vynamic’s Chris Wuenschel & Frank Longo, as well as AI Mobilization Offering Lead, Todd Quartiere, to discuss their exp…

In today’s competitive and dynamic pharmaceutical landscape, mastering the art of brand planning and management is crucial to success. In this episode, Jen and Mindy are joined by Vynamic’s Brand Strategy Offering Lead, Liza Flaherty, to discuss common challenges, best practices, and latest trends impacting the process of creating an effective bran…

Two years after the announcement that Veeva and Salesforce would part ways, Life Sciences organizations are racing to evaluate their options and select their CRM partner before the 2025 cutover. Jen is joined by Vynamic’s Life Sciences Commercial Operations Lead, Jeremy Shirey, and Tech & Digital Transformation Service Lead, Vince Annerhed-Harris a…

In this episode, Jen, Mindy, and Ryan discuss recent newsworthy items, including the Supreme Court’s overturning of Chevron Deference and what this will mean for the health industry, as well as strategic shifts made by Walgreens under their new CEO, and the ongoing impact of Microsoft’s global IT outage on health systems, hospitals, and clinics. Po…

One of the advantages of serving clients across multiple geographies is that Vynamic can see firsthand how the differences in health systems play out in terms of spend, outcomes, and innovation. Jen & Ryan are joined by Vynamic London’s Oliver White to discuss key differences between the health systems in each country and what they can learn from o…

The FemTech sector has seen major growth in the last 5 years – and as the healthcare industry increases its focus on equity, is only projected to keep growing. In this Women’s History Month episode, Jen is joined by Vynamic’s Diana Kuritza, Jen Proietti-Fox and HelloGina’s Daphne Petrich to discuss the latest trends in FemTech and what it could mea…

The re-emergence of clinical research into psychedelics as mental health treatment has become a promising development – particularly in light of the current global mental health crisis. However, persistent stigma around psychedelics, regulatory hurdles, and research challenges are a few factors to overcome before psychedelics could be more widely a…

In this episode, Jen, Karan, and Ollie discuss recent newsworthy items, including the political shifts taking place across Europe and their potential impact to the pharma sector, as well as the challenges posed by medicine stockpiling and breakthroughs in hemophilia treatment. Podcast Tags: healthcare, healthcare news, public health, Labour, pharma…

The healthcare industry is in an unprecedented era of change as rapidly advancing technologies, changing consumer expectations, and rising costs force organizations to adapt. With a landscape that is becoming increasingly more competitive, organizations are facing a choice: transform traditional models of healthcare delivery or face the risk of bei…

In this episode, Jen, Mindy, and Ryan discuss recent newsworthy items, including the recent ruling by the United States Supreme Court on access to the abortion pill mifepristone, the declaration of bankruptcy by the Massachusetts-based Steward Health Care system, and the combination flu and COVID-19 vaccine under development by Moderna. Podcast Tag…

In this episode, Jack and Jen welcome special guest Nico Renner, Patient Partnership Lead at Roche, to discuss the transformative impact of social media on patient engagement. Together they explore how pharmaceutical companies can embrace this shift to enhance patient interaction and outcomes. Podcast Tags: healthcare, life sciences, patient engage…

In this episode, Jack, Jen, and Ollie discuss recent newsworthy items, including a roundup of key insights from the NEXT Pharma Summit, AstraZeneca’s announcements at ASCO, and the NHS’s groundbreaking trials for personalised cancer vaccines. Podcast Tags: healthcare, healthcare news, NEXT Pharma Summit, life sciences, Novartis, generative AI, Lill…

As healthcare organizations strive to accelerate innovations through Artificial Intelligence (AI), it can be complicated to navigate through the number of possibilities that exist and know how to get started. In this episode, Jen is joined by Vynamic’s Tech & Digital Transformation Service Lead, Vince Annerhed-Harris and Lantern’s Chief Experience …

In this Trending News US episode, Jen, Mindy, and Ryan discuss recent newsworthy items, including legislation aimed at addressing drug shortages and telehealth regulations, the ongoing legal challenges to the Inflation Reduction Act, and the role of ride share apps in healthcare. Podcast Tags: healthcare, healthcare news, health policy, drug shorta…

During Fierce Life Science’s MASS East, Medical Affairs leaders gathered to address current challenges and share industry best practices. In this episode, Jen is joined by Vynamic’s Tamaron Bertelli and Head of Life Sciences Europe, Gemma Pfister to share what they learned about transformation and operating with impact. To receive a copy of Vynamic…

In this Trending News Europe episode, Jack, Jen, and Ollie discuss a few recent newsworthy items, including an increase in cyberattacks on the healthcare sector, Europe’s plan to future-proof its Biotech Sector and New Research from the University of Oxford into psilocybin as a potential treatment for depression. Podcast Tags: healthcare, healthcar…

As competitive and regulatory pressures increase, Life Sciences organizations are tightening their timelines and budgets when bringing products to market. In this environment, it’s become essential to start commercialization planning earlier to ensure a successful launch and hit revenue targets. In this deep dive episode, Jen is joined by Vynamic’s…

In this episode, Mindy, Ryan, and Jen discuss recent newsworthy items, including the FDA approval of Rejoyn, the first prescription digital treatment for major depressive disorder. They also discuss the ongoing drug shortage crisis, as well as changes coming out of the Centers for Medicare & Medicaid Services and the impact those decisions will hav…

While the health industry is not always an early adopter of new technologies, the growth of generative artificial intelligence (GenAI) has empowered organizations to start transforming their AI aspirations into actions. In this episode, Mindy and Jen are joined by Vynamic’s Innovation Lead, Michael Hudson, and Responsible AI Lead, Todd Quartiere, t…

In this Trending News Europe episode, Jack, Jen, and Ollie discuss recent newsworthy items from across Europe, including the impact of and deterrents against “no shows” at medical appointments, the role bacteria play in cancer treatment, and inequalities in the rare disease market, along with the steps being taken to ease these issues. Podcast Tags…

In recent years, we’ve seen an increasing number of Life Sciences companies publicly declare commitments to sustainability efforts as a result of increased pressure from governments, customers, and research. Trending Health UK’s Ollie May sits down with two members of Vynamic’s Sustainability Council, Rosanna Vellacott and Matt O’Dell, to discuss w…

In this Trending News US episode, Jen, Mindy, and Ryan discuss recent newsworthy items, including the introduction of rebate credits by CVS to account for more biosimilars entering the market, as well as a recent ruling by a federal appeals court that drugmakers cannot restrict 340B program offerings from community and specialty pharmacies. Finally…

One of the core tenets of the omnichannel philosophy is continuous learning and refinement – bringing together experience and data to evolve the marketing and model. Jen is joined by Vynamic’s Customer Experience Transformation Lead Mike Zapiec and Omnichannel Offering Lead Josh Padams to discuss what we’ve learned partnering with clients to build …

In this episode, Jack, Ollie, and Jen discuss a substantial investment package in the UK’s Life Sciences and manufacturing sectors, the role of an AI chatbot in bridging Europe\’s mental health care gap, and how Spain is reshaping pharmaceutical supply chains in Europe. Podcast Tags: healthcare, Europe, healthcare news, manufacturing, research, AI,…

The obesity drug market has grown dramatically in the last few years, especially with the help of social media and influencers. The immense popularity of anti-obesity medications has transformed a health industry development into a cultural phenomenon. While this market has so much opportunity, it also faces supply issues and coverage gaps. Mindy a…

Since it was signed into law in 2022, the health industry has been abuzz about the longer-term impact of the Inflation Reduction Act. In this episode, Jen & Mindy sit down to discuss recent headlines and developments around this landmark legislation and what Life Sciences companies should expect over the course of the next year. For more perspectiv…

In this episode, Mindy, Ryan, and Jen discuss recent newsworthy items, including the ruling by Alabama’s Supreme Court that frozen embryos can be legally regarded as “extrauterine children” under state law, and the impact this decision has had on in vitro fertilization (IVF) procedures. They also cover the release of additional guidance from CMS on…

In this episode, Jack, Ollie, and Jen discuss some recent European-based newsworthy items, covering a prominent oncology society\’s push for tumor classification reform that could have profound impacts on cancer survival rates, the critical need for measles vaccination, and Sweden\’s pioneering use of drones in cardiac arrest intervention. Podcast …

Over the last few years, the MedTech market has been navigating an unpredictable environment due to macro-economic factors and pandemic-driven activity. As we start off 2024, there’s a prevailing feeling that this market is finally starting to stabilize. In this episode, Jen is joined by Vynamic’s Anila Patel and Head of Health Technology Sector, M…

In this episode, Jen sits down with Vynamic’s Deal Activation & Partnership Enablement Service Leads, Senior Director Kevin Fletcher and Executive Sean Martin, to discuss recent newsworthy items coming out of the J.P. Morgan Healthcare Conference, including the major acquisitions and deals announced, particularly those focused on AI and digital inn…

Within Life Sciences companies, Medical Affairs teams are tasked with gathering and communicating scientific data, a job that has only grown in importance as therapies have grown more complex and stakeholders have multiplied. Stretched in many directions and under high scrutiny, Medical Affairs teams need to be able to effectively measure and commu…

In this episode, Jack, Ollie, and Jen discuss some recent European-based newsworthy items, including the potential impact of Wegovy in reducing excess deaths in the UK, a groundbreaking report on minimising the environmental footprint of surgical care, and Lithuania\’s innovation wave in biotech and MedTech. Podcast Tags: healthcare, healthcare new…

The US Pharmacy Industry is the largest in the world, with many different players involved in ensuring pharmaceutical products reach consumers. These channels and distribution outlets have drastically changed over the years and will only continue to evolve. The pharmacy channel has reimagined how they are reaching patients, managing risks, and deri…

In this episode, Mindy, Ryan, and Jen discuss recent newsworthy items, including the announcement that Bristol Myers Squibb is purchasing RayzeBio, the use of artificial intelligence in discovering antibiotics that stop MRSA infections, and recent reports revealing an increase in medical errors at hospitals owned by private equity firms. Podcast Ta…

In this special episode, we conclude our annual series on the biggest health industry trends of the next year. Jen sits down with Vynamic Senior Executives Karen Baldry, Mindy McGrath, and Ryan Hummel, and Executives Mary Virzi and Saurabh Raman to discuss the five trends they expect to be most impactful in 2024. These trends include 1) policy impl…

In this special minisode, we continue our annual series on next year’s biggest health industry trends. Jen is joined by Vynamic Executive & Head of Health Technology Mary Virzi to discuss the five MedTech trends Mary expects to be most impactful in 2024. These trends include 1) increased research & development spend, 2) embracing remote patient mon…

In this special minisode, we continue our annual series on next year’s biggest health industry trends. Jen is joined by Vynamic Senior Executive & Head of Life Sciences Karen Baldry to discuss the five Life Sciences trends Karen expects to be most impactful in 2024. These trends include 1) balancing innovation & affordability, 2) launching for valu…

In this episode, Jen is joined by members of Vynamic’s London office to unpack key insights from two recent conferences. First, Senior Executive Gemma Pfister and Director Nick Fletcher discuss the recent Evidence Life Science Medical Affairs Insights & Omnichannel Conference in London. Then, Senior Directors Jack Young and Owen Thomas cover the Ne…

In this special minisode, we continue our annual series on next year’s biggest health industry trends. Jen is joined by Vynamic Executive & Head of Payers Saurabh Raman to discuss the five Payer trends Saurabh expects to be most impactful in 2024. These trends include 1) product diversification and a strategic shift to government markets, 2) regula…

In this special minisode, we begin our annual series on next year’s biggest health industry trends. Jen is joined by Vynamic Senior Executive & Head of Providers Ryan Hummel to discuss the five Provider trends Ryan expects to be most impactful in 2024. These trends include 1) increased financial stability, 2) digitizing the patient experience, 3) a…

Deals, mergers, partnerships, and acquisitions are key mechanisms as health organizations look to enter new markets, differentiate their value proposition, and achieve growth strategies. Despite a less than favorable economic environment, the health industry has seen some major headlines in this space this year. Jen and Mindy are joined by Vynamic’…

Payer organizations are betting big on government markets, with some abandoning commercial opportunities entirely. In this episode, Jen is joined by two leaders in Vynamic\’s Health Services sector, Executive Saurabh Raman and Senior Director Keith Sutter to explore what this trend means for the health industry, the complexities involved in these m…

In this episode, Mindy and Jen catch up on the impact that the Inflation Reduction Act has had on the health industry over the last year and look ahead to how life sciences organizations, payors, and providers can prepare for the changes that this legislation will cause. If you missed our initial coverage of the Inflation Reduction Act, check out o…

The growth of the biotech industry has become a recurring topic on Trending Health episodes, from headlines about Novo Nordisk products Ozempic and Wegovy, to the emergence of Moderna as a household name thanks to their mRNA COVID-19 vaccine. As more biotech companies emerge into the market, they bring with them a mix of challenges and opportunitie…

The global medical device market is expected to grow at a compound rate of nearly 5% in the next few years – fueled by a forecasted uptick in product launches. On this episode, Jen is joined by Vynamic\’s Head of Health Technology Sector Mary Virzi and Senior Manager Christina Nikolos, to discuss how MedTech companies should approach launch to capi…

Cell and gene therapies present an enormous opportunity for patients – the ability to insert or adapt genetic material is a true breakthrough for precision medicine and brings hope to those with previously incurable diseases. However, bringing these therapies to patients comes with enormous complexity – from research and approval through manufactur…

In this episode, Jack, Ollie, and Jen discuss some recent EU-based newsworthy items, including the importance of ethnicity data and its impact on healthcare systems (0.35), exciting and emerging retail health opportunities (8.08), and a landmark report calling for urgent investment in digital health literacy (16.20). Podcast Tags: healthcare, healt…